English pubs to reopen; German district is back on lockdown

White House coronavirus advisor Dr. Anthony Fauci, along with three other top U.S. health officials, are slated to answer questions from members of Congress about the national response to the pandemic on Tuesday. Top officials from the Centers for Disease Control and Prevention, the Food and Drug Administration and the Department of Health and Human Services are expected to testify about what each agency has done in response to the coronavirus outbreak.  This is CNBC’s live blog covering all the latest news on the coronavirus outbreak. This blog will be updated throughout the day as the news breaks. Global cases: More than 9.11 millionGlobal deaths: At least 472,541U.S. cases: More than 2.31 millionU.S. deaths: At least 120,402The data above was compiled by Johns Hopkins University.University of Michigan pulls out of hosting presidential debate, citing health concerns9:30 a.m. ET — The University of Michigan said it will be pulling out of its agreement with the Commission on Presidential Debates to host a general election presidential debate on its campus in the fall.The debate will still take place on Oct. 15, but will instead be held in Miami at the Adrienne Arsht Center for the Performing Arts of Miami-Dade County, according to a statement by the commission.The University of Michigan’s decision to back out was rooted in concerns over the public health risks of bringing candidates, campaigns and the media to campus during the pandemic, the Detroit Free Press reported Monday, citing sources with direct knowledge of the matter.University President Mark Schlissel wrote in a letter to the committee that hosting the debate is no longer feasible, given the public health and safety issues which accompany bringing so many visitors to the Ann Arbor, Mich. campus. —Alex HarringDaily new cases in the U.S. trend upwardSanofi CEO says the company could contribute two successful coronavirus vaccines8:56 a.m. ET — Sanofi CEO Paul Hudson told CNBC both of the French drugmaker’s vaccine pursuits could be successful in preventing Covid-19.”The world needs billions of doses. We want to make sure every country, everybody that needs that protection, can get it,” Hudson said on “Squawk Box.” “We think we’ll definitely play a part with one, and maybe even both of our vaccines.”Hudson’s comments come after Sanofi announced a potential $2 billion deal with U.S. biotech firm Translate Bio to develop a Covid-19 vaccine. Sanofi has already entered a vaccine partnership with GlaxoSmithKline, a British pharmaceutical company.Hudson touted Translate Bio’s experience working on therapeutics using mRNA technology, which tells human cells to produce specified proteins in order to produce an immune response to a particular disease. The vaccine candidate from Sanofi and Translate Bio could be ready “later in 2021,” Hudson said.”One of the reasons why we went deeper into this collaboration was because they’ve been on mRNA for 10 years. They know how it make it scaled, which has never been done before with any other company. Once we’ve cracked it, which we think we will, we’ll be able to get to large volumes very quickly,” he said. —Kevin StankiewiczEngland pubs, restaurants and hotels to reopen on July 4People are seen buying takeaway pints at a pub on Wandsworth Common on May 28 2020 in London, England.Peter Summers | Getty Images8:05 a.m. ET — British Prime Minister Boris Johnson announced England’s pubs, restaurants and hotels will be permitted to reopen on July 4 as part of the country’s next phase of a resumption of business, according to a Reuters report. “All hospitality indoors will be limited to table service and our guidance will encourage minimal staff and customer contact,” he said in parliament, according to Reuters. “We will ask businesses to help NHS Test and Trace respond to any local outbreaks by collecting contact details from customers.” —Sara SalinasGerman district goes back into lockdown after outbreak at meat processing plantA man speaks to foreign labourers inside an area secured by local police forces within an apartment complex used by the Toennies meat company to house labourers from eastern Europe during the coronavirus pandemic on June 20, 2020 in Verl near Guetersloh, Germany.Alexander Koerner7:13 a.m. ET — A district in Germany that has seen an acute outbreak of coronavirus cases at a meat-processing plant is being put back into lockdown, the premier of North Rhine-Westfalia said. State premier Armin Laschet said he was putting the district of Guetersloh, home to around 360,000 people, back under lockdown until June 30. The move comes after at least 1,000 workers at a meat processing plant in the area contracted Covid-19.Germany has been lauded throughout the coronavirus crisis in Europe as a country that had seemingly managed to control the virus’ spread, largely through an organized and early contact tracing system. Now, however, the country has seen a resurgence of cases due to several localized outbreaks in different parts of the country.As well as the outbreak in Guetersloh, a large Covid-19 outbreak in the district of Goettingen in Lower Saxony was traced to family gatherings and another, in Magdeburg in the state of Saxony-Anhalt, emerged in several schools that are now closed. In Berlin, an outbreak of 85 cases has been linked to members of a religious community. —Holly EllyattAstraZeneca’s potential vaccine shows promise in pigs with two shotsAstraZeneca’s building in Luton, Britain.Tim Ireland | Xinhua News Agency | Getty Images7:03 a.m. ET — AstraZeneca’s potential coronavirus vaccine showed some promise in a trial of pigs, which found that two doses of the shot produced more antibodies than one dose. The research, which was published by The Pirbright Institute, suggests that a two-shot approach of the Oxford University-developed vaccine candidate might be most effective in preventing Covid-19 infection.”The researchers saw a marked increase in neutralizing antibodies, which bind to the virus in a way that blocks infection,” the Pirbright team said in a statement. However, the potential vaccine still must prove it’s safe and effective in humans as well.The potential vaccine, also known as AZD1222, is being developed in partnership between researchers at Oxford University and pharmaceutical company AstraZeneca. The candidate is already in human trials and the company previously said it hopes to have data on whether it’s effective in preventing Covid-19 later this year. —Will FeuerRead CNBC’s previous coronavirus live coverage here: Chinese firm gets approval for potential vaccine trials; euro zone downturn eases


Source link